Investment Banking and Brokerage

Evercore

Evercore Reports Q1 2026 Earnings

Evercore Publishes Annual Report, Reveals Record Performance and Expands in UK

Evercore released FY2026 Q1 earnings on April 29 Pre-Market (EST), actual revenue USD 1.392 B (forecast USD 1.167 B), actual EPS USD 7.2 (forecast USD 4.785)

Evercore to Release FY2026 Q1 Earnings on April 29 Pre-Market EST, Forecast Revenue USD 1.167 B, EPS USD 4.785

Evercore Announces Acquisition of Robey Warshaw to Enhance Global Expansion

Sarah K Williamson Buys Evercore Stocks

Evercore Sees Net Income Soar 56% in 2025, Completes Robey Warshaw Acquisition

Evercore released FY2025 earnings on February 4 Pre-Market (EST), actual revenue USD 3.857 B (forecast USD 3.683 B), actual EPS USD 14.05 (forecast USD 13.1777)

Evercore released FY2025 Q4 earnings on February 4 Pre-Market (EST), actual revenue USD 1.289 B (forecast USD 1.123 B), actual EPS USD 4.7619 (forecast USD 3.8414)

Evercore Advisor Fees Hit Record in 2025 with 33% Year-Over-Year Growth

Evercore to release FY2025 Q4 earnings on February 4, 2026 Pre-Market EST, forecast revenue USD 1.123 B, EPS USD 3.8414

Evercore Inc Named Best Boutique Investment Bank by BofA Securities

Director Pamela Carlton Sells Evercore Partners Stock

Evercore Secures Permit to Open Office in Saudi Arabia

Morgan Stanley Analyst Downgrades Evercore Partners to Hold

UK Government Hires Evercore to Study Steel Industry Future

Evercore Partners to Hold Eighth Annual Healthcare Conference

Evercore Appoints Executives and Opens New Office

Ryan Kenny Reiterates Buy Rating on Evercore Partners

Evercore released FY2025 Q3 earnings on October 29 Pre-Market (EST), actual revenue USD 1.039 B (forecast USD 964.92 M), actual EPS USD 3.41 (forecast USD 2.94)

InMed Pharmaceuticals

AMPLITECH GROUP INC. USD0.001 S/R 20/11/26 SER B

Amesite

CN Energy

AMPLITECH GROUP INC. COM USD0.001 (S/R 18/07/2026)

NextNRG

Meiwu Tech

Generation Income Properties

MetaVia

OceanPal

Ordinary dividend (cash)

Ex Date: 2026.05.29 (EST), Cash dividend 0.89 USD

Evercore ISI senior managing director Julian Emanuel discusses shifting market sentiment, noting retail investor bearishness and high profit margins on ‘Making Money.’

A lot of these sentiment indicators have been 'misleading': Evercore ISI's Julian Emanuel

Hemab Therapeutics Holdings, Inc. has priced its initial public offering (IPO) at $18.00 per share, offering 16,750,000 shares, with an option for underwriters to purchase an additional 2,512,500 shares. The IPO is expected to raise approximately $301.5 million and will begin trading on the Nasdaq under the ticker symbol "COAG" on May 1, 2026. The offering is set to close around May 4, 2026, subject to customary conditions. Goldman Sachs, Jefferies, and Evercore ISI are the joint book-running managers for the offering.

StockTitan

Goldman Sachs

Jefferies Financial

Nasdaq

GS Hldg R

Hemab Therapeutics Announces Pricing of Upsized Initial Public Offering | COAG Stock News

Earnings Watch

Evercore | 8-K: FY2026 Q1 Revenue: USD 1.392 B

Evercore Reports Record First Quarter 2026 Revenues; Increases Quarterly Dividend to $0.89 Per Share | EVR Stock News

Evercore Reports Record First Quarter 2026 Revenues; Increases Quarterly Dividend to $0.89 Per Share | EVR Stock News

Evercore Inc (EVR) has launched new options for November 20th expiration, providing opportunities for investors. A put contract at a $340 strike price offers a premium of $36.60, allowing a potential cost basis of $303.40 for shares. Conversely, a call contract at a $350 strike price has a premium of $40.20, yielding a total return of 13.89% if exercised. The odds of the put expiring worthless are 59%, while the call has a 45% chance. Both contracts exhibit significant implied volatility, indicating potential trading strategies for investors.

nasdaq

S&P 500

Synthomer PLC

EVR November 20th Options Begin Trading

Evercore (EVR) is anticipated to announce a dividend increase in April, extending its 18-year history of regular growth. Analysts predict an annual dividend of approximately $3.50 per share, translating to a quarterly dividend of about $0.875, marking a 4.16% rise from the current $0.840. The company has a five-year dividend growth rate of 2.45% and a payout ratio of 23.14%. Evercore's dividend quality ratings include A+ for safety and growth, and A- for consistency. Q1 2026 financial results will be released on April 29, 2026.

Evercore Q1 dividend preview: 18-year streak set for another raise

Evercore(EVR.US)

A lot of these sentiment indicators have been 'misleading': Evercore ISI's Julian Emanuel

Hemab Therapeutics Announces Pricing of Upsized Initial Public Offering | COAG Stock News

Evercore | 8-K: FY2026 Q1 Revenue: USD 1.392 B

Evercore Reports Record First Quarter 2026 Revenues; Increases Quarterly Dividend to $0.89 Per Share | EVR Stock News

EVR November 20th Options Begin Trading

Evercore Q1 dividend preview: 18-year streak set for another raise

Trending